{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:10:19Z","timestamp":1784002219332,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The association between biomarkers and the risk of gestational diabetes mellitus (GDM) or preeclampsia (PE) has been extensively studied. However, there is still a lack of convenient, specific, and sensitive indicators for early identification of GMD and PE. Therefore, we conducted a meta-analysis of published articles to investigate the value of afamin circulating levels in the early diagnosis of GDM and PE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched the PubMed, Embase, Cochrane Library, and Web of Science databases for English studies published before November 16, 2022, that examined the association between afamin and GDM or PE. In addition, we searched Clinicaltrials.gov for the relevant completed and ongoing clinical trials. Pooled standard mean differences (SMDs) and weighted mean differences (WMDs) with 95% confidence intervals (CIs) were used to compare the levels of afamin in different groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eleven studies were included in our analysis (N = 3047 participants: 1195 GDM, 1407 non-GDM, 195 PE, and 250 non-PE). Subgroup analysis based on different blood collection periods found that the plasma afamin levels in pregnant women with GDM in the first trimester were significantly higher than those in healthy pregnant women (SMD = 0.481, 95% CI: 0.280-0.682), but the analysis showed the opposite results in the second and late stages (SMD = 0.292, 95% CI: -0.092-0.676). The plasma afamin levels of pregnant women with PE in the first trimester (SMD = 0.808, 95% CI: 0.558-1.059) and second\/third trimesters (SMD = 0.904, 95% CI: 0.570-1.239) were significantly higher than those in healthy pregnant women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The plasma afamin levels in pregnant women with GDM in the first trimester were significantly higher than those in healthy pregnant women, but the analysis showed the opposite results in the second and third trimesters. The plasma afamin levels in pregnant women with PE in the first, second, and third trimesters were significantly higher than those in healthy pregnant women. Additional large-scale prospective studies are desired to verify these findings, and it is recommended that afamin should be included as a routine diagnostic test for women with GDM and PE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=339171<\/jats:uri>, identifier CRD42022339171.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1157114","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T05:53:03Z","timestamp":1679464383000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Serum afamin levels in predicting gestational diabetes mellitus and preeclampsia: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Ying","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2337\/diab.40.2.S197","article-title":"Summary and recommendations of the third international workshop-conference on gestational diabetes mellitus","volume":"40","author":"Metzger","year":"1991","journal-title":"Diabetes."},{"key":"B2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.amjmed.2019.04.026","article-title":"Presentation and mortality of cryptococcal infection varies by predisposing illness: A retrospective cohort study","volume":"132","author":"Hevey","year":"2019","journal-title":"Am J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0702","article-title":"Sulfated progesterone metabolites that enhance insulin secretion via TRPM3 are reduced in serum from women with gestational diabetes mellitus","volume":"71","author":"Fan","year":"2022","journal-title":"Diabetes."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12854","article-title":"Prevalence of gestational diabetes mellitus in mainland China: A systematic review and meta-analysis","volume":"10","author":"Gao","year":"2019","journal-title":"J Diabetes Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2020.948","article-title":"The clinical characteristics of gestational diabetes mellitus in Korea: A national health information database study","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"New Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","article-title":"Gestational diabetes mellitus","volume":"5","author":"McIntyre","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B8","doi-asserted-by":"publisher","first-page":"l2381","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: Pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"B9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet (London England)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.47419\/bjbabs.v1i01.31","article-title":"Baghdad J","volume":"1","author":"Nasser","year":"2020","journal-title":"Biochem Appl Biol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12442","article-title":"Lifestyle intervention can reduce the risk of gestational diabetes: A meta-analysis of randomized controlled trials","volume":"17","author":"Song","year":"2016","journal-title":"Obes Rev an Off J Int Assoc Study Obes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042973","article-title":"Effect of treatment of gestational diabetes mellitus on pregnancy outcomes","volume":"352","author":"Crowther","year":"2005","journal-title":"New Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0719","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26725","article-title":"Evaluation of maternal serum afamin and vitamin e levels in pregnant women with COVID-19 and its association with composite adverse perinatal outcomes","volume":"93","author":"Erol","year":"2021","journal-title":"J Med virology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.11.031","article-title":"First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women","volume":"476","author":"Tramontana","year":"2018","journal-title":"Clinica chimica acta; Int J Clin Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2017.12.014","article-title":"Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies","volume":"62","author":"Tramontana","year":"2018","journal-title":"Placenta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.723650","article-title":"The clinical values of afamin, triglyceride and PLR in predicting risk of gestational diabetes during early pregnancy","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-018-4897-z","article-title":"Afamin: An early predictor of preeclampsia","volume":"298","author":"K\u00f6ninger","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1818201","article-title":"Is afamin a potential early biomarker for subsequent development of preeclampsia? A nested case control study","volume":"34","author":"\u00c7ali\u015f","year":"2021","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0179","article-title":"Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: The st. carlos gestational diabetes study","volume":"37","author":"Duran","year":"2014","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/bi026513v","article-title":"Characterization of the vitamin e-binding properties of human plasma afamin","volume":"41","author":"Voegele","year":"2002","journal-title":"Biochemistry."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EC-14-0053","article-title":"Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome","volume":"3","author":"Koninger","year":"2014","journal-title":"Endocr Connect"},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1477-7827-12-88","article-title":"Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome","volume":"12","author":"Seeber","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0201","article-title":"Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: A pooled analysis in more than 20,000 individuals","volume":"40","author":"Kollerits","year":"2017","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s42000-018-0051-3","article-title":"Metabolic syndrome: An update on diagnostic criteria, pathogenesis, and genetic links","volume":"17","author":"Zafar","year":"2018","journal-title":"Hormones (Athens Greece)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12958-018-0338-x","article-title":"Is afamin a novel biomarker for gestational diabetes mellitus? a pilot study","volume":"16","author":"K\u00f6ninger","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2021.1928754","article-title":"Hepatokine levels during the first or early second trimester of pregnancy and the subsequent risk of gestational diabetes mellitus: A systematic review and meta-analysis","volume":"26","author":"Cai","year":"2021","journal-title":"Biomarkers."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3855-6","article-title":"Accuracy of circulating adiponectin for predicting gestational diabetes: A systematic review and meta-analysis","volume":"59","author":"Iliodromiti","year":"2016","journal-title":"Diabetologia."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.07.015","article-title":"First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus","volume":"64","author":"Syngelaki","year":"2015","journal-title":"Metabolism."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00348","article-title":"Placental protein 13 (PP13) - a placental immunoregulatory galectin protecting pregnancy","volume":"5","author":"Than","year":"2014","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2014.973397","article-title":"Prediction of gestational diabetes mellitus in the first trimester: comparison of c-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices","volume":"28","author":"Ozgu-Erdinc","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b20-01043","article-title":"Identification and validation of combination plasma biomarker of afamin, fibronectin and sex hormone-binding globulin to predict pre-eclampsia","volume":"44","author":"Uchida","year":"2021","journal-title":"Biol Pharm Bulletin"},{"key":"B33","article-title":"Placenta changes in pregnancy with gestational diabetes","volume":"57","author":"Edu","year":"2016","journal-title":"Romanian J morphology embryology = Rev roumaine morphologie embryologie"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1064-9","article-title":"Effects of management in gestational diabetes mellitus with normal prepregnancy body mass index on pregnancy outcomes and placental ultrastructures: A prospective cohort study","volume":"54","author":"Han","year":"2016","journal-title":"Endocrine."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1157114\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T05:53:06Z","timestamp":1679464386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1157114\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":34,"alternative-id":["10.3389\/fendo.2023.1157114"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1157114","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"article-number":"1157114"}}